This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $728 | Check With Us |
500mg | $1192 | Check With Us |
1g | $1788 | Check With Us |
Cat #: V15231 CAS #: 2095432-55-4 Purity ≥ 98%
Description: SR-18292 (SR18292) is a novel and potent inhibitor of PGC-1α (PPAR gamma coactivator-1α), which is able to reduce blood glucose, strongly increase hepatic insulin sensitivity, and improve glucose homeostasis in dietary and genetic mouse models of T2D.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 366.50 |
---|---|
Molecular Formula | C23H30N2O2 |
CAS No. | 2095432-55-4 |
SMILES Code | CC(C=C1)=CC=C1CN(C(C)(C)C)CC(O)COC2=CC=CC3=C2C=CN3 |
Synonyms | SR-18292; SR 18292; SR18292 |
Protocol | In Vitro | The transcriptional coactivator PGC-1α plays a pivotal role in energy homeostasis by co-activating transcription factors that regulate fat and glucose metabolism. SR-18292 increases the interaction of PGC-1α with the acetyl transferase GCN5 and reduces co-activation of nuclear hormone receptor HNF4α by PGC-1α. SR-18292 suppresses HNF4α/PGC-1α gluconeogenic transcriptional function. By increasing the interaction of GCN5 with PGC-1α, SR-18292 increases the acetylation of specific PGC-1α lysine residues that might subsequently decrease its gluconeogenic activity. |
---|---|---|
In Vivo | SR-18292 reduces fasting blood glucose, increases hepatic insulin sensitivity and improves glucose homeostasis in diabetic mice. The high fat diet (HFD) fed mice, a dietary model of obesity and T2D, are treated with SR-18292 (45mg/kg) via I.P. injection for 3 consecutive days and again on day 4 before measuring fasting blood glucose. Strikingly, mice that are treated with SR-18292 have significantly lower levels of fasting blood glucose concentrations compared to matched vehicle-treated control mice. The induction of gluconeogenic gene expression is a regulatory component of the response to fasting. Importantly, gluconeogenic gene expression, specifically that of Pck1, is inhibited in livers isolated from mice treated with SR-18292. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.7285 mL | 13.6426 mL | 27.2851 mL | 54.5703 mL |
5mM | 0.5457 mL | 2.7285 mL | 5.4570 mL | 10.9141 mL |
10mM | 0.2729 mL | 1.3643 mL | 2.7285 mL | 5.4570 mL |
20mM | 0.1364 mL | 0.6821 mL | 1.3643 mL | 2.7285 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.